(S)-Azetidine-2-carboxylate
1895
onate) as a yellow oil. This was employed for the next
step without further purification.
A small portion was purified by preparative TLC
added, and the mixture was heated to 40 ꢀC for 7 h. A
similar workup and purification to that described for 3a
gave 3b as a pale yellow oil (417 mg, 95%). IR ꢁmax
cmꢁ1: 1761, 1732, 1252, 1101; NMR ꢂH (270 MHz,
CDCl3): 1.26 (6H, t, J ¼ 7:1 Hz), 1.28 (3H, d, J ¼
6:4 Hz), 2.39–2.55 (2H, m), 3.00 (1H, ddd, J ¼ 3:0, 6.5,
7.9 Hz), 3.14 (1H, ddd, J ¼ 7:4, 7.4, 7.9 Hz), 3.73 (1H,
q, J ¼ 6:4 Hz), 4.06–4.39 (4H, m), 7.14–7.34 (5H, m).
When the reaction was quenched prior to cyclization
under a low dose of TBAI, the C-alkylated form (6) was
isolated as an intermediate: NMR ꢂH (270 MHz, CDCl3):
1.10 (3H, t, J ¼ 7:1 Hz), 1.22 (3H, t, J ¼ 7:1 Hz), 1.34
(3H, d, J ¼ 6:8 Hz), 2.14–2.26 (1H, m), 2.43–2.54 (1H,
m), 3.05–3.17 (2H, m), 3.73 (1H, q, J ¼ 6:8 Hz), 7.17–
7.26 (5H, m).
[developed with hexane–EtOAc (4:1) with a trace of
22
triethylamine]. ½ꢀꢂ
ꢁ64:5ꢀ (c 1.1, EtOH); IR ꢁmax
D
cmꢁ1: 3338, 1757, 1739, 1225, 1153; NMR ꢂH (270
MHz, CDCl3): 1.33 (3H, d, J ¼ 6:6 Hz), 2.18 (1H, br),
3.62 (3H, s), 3.69 (3H, s), 3.71 (1H, q, J ¼ 6:6 Hz), 3.87
(1H, s), 7.15–7.29 (5H, m); NMR ꢂC (67.5 MHz, CDCl3):
24.46, 52.67 (ꢃ2), 56.41, 62.54, 126.70 (ꢃ2), 127.24,
128.36 (ꢃ2), 143.47, 168.42, 169.33. The IR and NMR
spectra were in good accordance with those of the
racemate reported previously.14)
Dimethyl (10S)-1-(10-methyl)benzylazetidine-2,2-di-
carboxylate (3a). Cesium carbonate (134 mg, 0.41
mmol) was added to a solution of 4a (45.7 mg, 0.18
mmol) in DMF (0.7 ml), and the mixture was stirred for
10 min at room temperature. 1,2-Dibromoethane (23 ml,
0.267 mmol) was added, and the reaction mixture was
stirred for 14 h at room temperature and then for 22 h at
40 ꢀC. The reaction mixture was next diluted with a
phosphate buffer (0.1 M, pH 7.5) and extracted with
ethyl acetate. The extract was washed with brine, dried
over anhydrous sodium sulfate, and concentrated in
vacuo to give a crude product. Purification by prepara-
tive TLC [developed with hexane–EtOAc (4:1) with a
trace of triethylamine] afforded 3a (49.9 mg, 99%) as a
yellow oil. Bulb-to-bulb distillation gave an analytical
Another by-product with an imine structure (7): NMR
ꢂH (270 MHz, CDCl3): 1.47 (3H, d, J ¼ 6:4 Hz), 1.23
(3H, t, J ¼ 7:3 Hz), 1.24 (3H, t, J ¼ 7:3 Hz), 4.24 (2H,
q, J ¼ 7:3 Hz), 4.27 (2H, q, J ¼ 7:3 Hz), 4.58 (1H, q,
J ¼ 6:6 Hz), 7.10–7.28 (5H, m).
Methyl (2S,10S)-1-(10-methyl)benzylazetidine-2-car-
boxylate (2a) and methyl (2R,10S)-1-(10-methyl)benzyl-
azetidine-2-carboxylate (2a). Lithium chloride (23 mg,
0.54 mmol), BHT (120 mg, 0.55 mmol) and molecular
sieves 3A (150 mg) were added to a solution of 3a
(47 mg, 0.17 mmol) in DMSO (0.25 ml), and the mixture
was stirred for 1 h at room temperature. The reaction
mixture was then heated at 140 ꢀC for a further 2 h and,
after cooling, was diluted with a phosphate buffer
(pH 6.0, 0.1 M) and extracted three times with ethyl
acetate. The combined organic layer was washed with
brine, dried over anhydrous sodium sulfate, and con-
centrated in vacuo. The residue was purified by
preparative thin-layer column chromatography [devel-
oped with hexane–EtOAc (2:1) with a trace of trieth-
ylamine] to afford a mixture of (2S,10S)-2a and (2R,10S)-
2a (total 27.2 mg, 78%) as a pale yellow oil. The
sample. Bp 160–180 ꢀC at 0.15 mmHg (bath temp.);
21
½ꢀꢂ
ꢁ112:5ꢀ (c 1.0, EtOH); IR ꢁmax cmꢁ1: 1763,
D
1734, 1255, 1103; NMR ꢂH (270 MHz, CDCl3): 1.26
(3H, d, J ¼ 6:3 Hz), 2.41–2.56 (2H, m), 2.98 (1H, ddd,
J ¼ 3:0, 6.5, 7.9 Hz), 3.12 (1H, ddd, J ¼ 7:4, 7.4,
7.9 Hz), 3.70 (1H, q, J ¼ 6:3 Hz), 3.73 (3H, s), 3.76 (3H,
s), 7.20–7.33 (5H, m); NMR ꢂC (67.5 MHz, CDCl3):
21.83, 25.87, 48.40, 52.10, 52.17, 61.86, 72.99, 126.98,
127.47 (ꢃ2), 127.92 (ꢃ2), 142.67, 169.40, 170.80. Anal.
Found: C, 64.81; H, 6.94; N, 4.97%. Calcd. for
C15H19NO4: C, 64.97; H, 6.91; N, 5.05%.
1
diastereomeric ratio (2.7:1) was estimated from the H-
NMR spectra as shown next. These two components
were further purified by the same preparative TLC and
subsequent bulb-to-bulb distillation.
Eight-membered by-product resulting from the double
C- and N-alkylation (5): NMR ꢂH (400 MHz, CDCl3):
1.37 (6H, d, J ¼ 6:8 Hz), 2.27 (2H, ddd, J ¼ 5:8, 9.8,
15.1 Hz), 2.56 (2H, ddd, J ¼ 5:9, 9.6, 15.1 Hz), 3.12
(2H, ddd, J ¼ 5:8, 9.6, 9.9 Hz), 3.23 (2H, ddd, J ¼ 5:9,
9.8, 9.9 Hz), 3.46 (6H, s), 3.63 (1H, q, J ¼ 6:8 Hz), 3.74
(6H, s), 7.20–7.35 (10H, m); FAB-HRMS (Mþ þ Naþ,
m=z): 577.2502; calcd. for C30H38N2O8Na, 577.2526.
(2S,10S)-2a (Rf 0.40): Bp 150–170 ꢀC at 0.18 mmHg
22
(bath temp.); ½ꢀꢂ
ꢁ118:7ꢀ (c 1.1, EtOH); IR ꢁmax
D
cmꢁ1: 1753, 1730, 1196, 1174; NMR ꢂH (270 MHz,
CDCl3): 1.21 (3H, d, J ¼ 6:6 Hz), 2.16 (1H, dddd,
J ¼ 2:8, 8.0, 8.4, 8.6 Hz), 2.25 (1H, dddd, J ¼ 8:0, 8.0,
8.4, 8.6 Hz), 2.78 (1H, ddd, J ¼ 8:0, 8.0, 8.0 Hz), 3.09
(1H, ddd, J ¼ 2:8, 8.0, 8.0 Hz), 3.43 (1H, q, J ¼ 6:6 Hz),
3.74 (3H, s), 3.74 (1H, dd, J ¼ 8:4, 8.4 Hz), 7.18–7.33
(5H, m); NMR ꢂC (67.5 MHz, CDCl3): 20.85, 20.99,
49.62, 51.87, 63.89, 67.21, 127.04, 127.30 (ꢃ2), 128.14
(ꢃ2), 142.27, 173.44. Anal. Found: C, 71.26; H, 7.74; N,
6.35%. Calcd. for C13H17NO2: C, 71.21; H, 7.81; N,
Diethyl (10S)-1-(10-methyl)benzylazetidine-2,2-dicar-
boxylate (3b). Cesium carbonate (2.11 g, 6.47 mmol)
was added to a solution of 4b (408 mg, 1.42 mmol) in
DMF (5.0 ml), and the mixture was stirred for 10 min at
room temperature. 1,2-Dibromoethane (0.25 ml, 2.90
mmol) and tetra-n-butylammonium iodide (TBAI,
55 mg, 0.15 mmol) were then added, and the reaction
mixture was stirred for 15.5 h at room temperature.
Another portion of TBAI (479 mg, 1.30 mmol) was
1
6.39%. The H-NMR spectrum was identical with that
reported previously.9)
(2R,10S)-2a (Rf 0.15): Bp 150–170 ꢀC at 0.18 mmHg
19
(bath temp.); ½ꢀꢂ
þ48:9ꢀ (c 1.1, EtOH); IR ꢁmax
D